These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2787338)

  • 21. A study of local immunity in psoriasis.
    Ramirez-Bosca A; Martinez-Ojeda L; Valcuende-Cavero F; Castells-Rodellas A
    Br J Dermatol; 1988 Nov; 119(5):587-95. PubMed ID: 2905164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis.
    Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Ho VC; Chan LS; Hamilton TA; Tellner DC; Griffiths CE; Voorhees JJ
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):242-50. PubMed ID: 2138175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistologic evaluation of the effect of cyclosporine treatment on the lichen planus immune infiltrate.
    Mozzanica N; Cattaneo A; Legori A; Pigatto P; Finzi AF
    J Am Acad Dermatol; 1991 Apr; 24(4):550-4. PubMed ID: 2033128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophil chemotaxis in psoriasis before and after PUVA therapy.
    Guillot B; Guilhou JJ; Vendrel JP; Meynadier J
    Arch Dermatol Res; 1983; 275(1):19-22. PubMed ID: 6847241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporine in the treatment of psoriatic arthritis.
    Gupta AK; Matteson EL; Ellis CN; Ho VC; Tellner DC; Voorhees JJ; McCune WJ
    Arch Dermatol; 1989 Apr; 125(4):507-10. PubMed ID: 2930208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanisms of action of cyclosporin A in the treatment of psoriasis.
    Wong RL; Winslow CM; Cooper KD
    Immunol Today; 1993 Feb; 14(2):69-74. PubMed ID: 8447934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of the effect of cyclosporine in psoriasis in vivo: combined effects on activated T lymphocytes and epidermal regenerative maturation.
    Gottlieb AB; Grossman RM; Khandke L; Carter DM; Sehgal PB; Fu SM; Granelli-Piperno A; Rivas M; Barazani L; Krueger JG
    J Invest Dermatol; 1992 Mar; 98(3):302-9. PubMed ID: 1372027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of zinc therapy on neutrophil chemotaxis in psoriasis.
    Leibovici V; Statter M; Weinrauch L; Tzfoni E; Matzner Y
    Isr J Med Sci; 1990 Jun; 26(6):306-9. PubMed ID: 2380030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged occlusion in the treatment of psoriasis: a clinical and immunohistologic study.
    Griffiths CE; Tranfaglia MG; Kang S
    J Am Acad Dermatol; 1995 Apr; 32(4):618-22. PubMed ID: 7534777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of systemic cyclosporin A on interleukin-2 and epidermal growth factor receptor expression in psoriatic skin lesions.
    Horroccks A; Ormerod AD; Duncan JI; Thomson AW
    Clin Exp Immunol; 1989 Nov; 78(2):166-71. PubMed ID: 12412743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic and local administration of cyclosporine in the treatment of psoriasis.
    Griffiths CE
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 2):1242-6; discussion 1246-7. PubMed ID: 2277131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic, phenotypic, and functional analyses of T cells in patients with psoriasis undergoing systemic cyclosporin A treatment.
    Takashima A; Morita A
    J Invest Dermatol; 1991 Mar; 96(3):376-82. PubMed ID: 1672138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose cyclosporine effective in severe psoriasis: a double-blind study.
    Heule F; Meinardi MM; van Joost T; Bos JD
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):32-41. PubMed ID: 3289211
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunologic mechanisms in psoriasis.
    Gottlieb AB
    J Am Acad Dermatol; 1988 Jun; 18(6):1376-80. PubMed ID: 3290292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intralesional cyclosporin in psoriasis.
    Powles AV; Baker BS; McFadden JP; Valdimarsson H; Fry L
    Acta Derm Venereol Suppl (Stockh); 1989; 146():148-9; discussion 149-50. PubMed ID: 2609857
    [No Abstract]   [Full Text] [Related]  

  • 36. Resistant severe psoriasis controlled with systemic cyclosporine therapy.
    Picascia DD; Garden JM; Freinkel RK; Roenigk HH
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):58-62. PubMed ID: 3381303
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of cyclosporine on renal function in psoriasis patients.
    Messana JM; Rocher LL; Ellis CN; Fradin MS; VanGurp JR; Cantu-Gonzalez G; Parish TG; Wheeler SM; Voorhees JJ
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 2):1288-91; discussion 1291-3. PubMed ID: 2277137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporine in lamellar ichthyosis.
    Ho VC; Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Voorhees JJ
    Arch Dermatol; 1989 Apr; 125(4):511-4. PubMed ID: 2649010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
    Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
    J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the T cell in psoriasis and the action of cyclosporin in this disease.
    Fry L
    Acta Derm Venereol Suppl (Stockh); 1989; 146():133-4; discussion 134-5. PubMed ID: 2609854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.